Prediagnostic prescription patterns in multiple sclerosis: a UK-based longitudinal linked data study.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 42009602.
- Also identified by DOI 10.3399/BJGP.2025.0210.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Early detection of multiple sclerosis (MS) could improve patient outcomes. Changes in clinical activity before MS diagnosis may represent 'diagnostic windows' for earlier detection. To determine whether certain prescriptions are more common in patients with MS and examine prescription patterns prediagnosis in the UK. Case-control study using routinely collected primary care data. Patients in the case group had an MS diagnosis (2001-2022) and patients in the control group were matched by birth year. Multivariable conditional logistic regression adjusting for sex and socioeconomic status (SES) examined associations between MS diagnosis and prescriptions for anxiety/depression, migraine, lower urinary tract symptoms (LUTS), urinary tract infection (UTI) treatments, sleep disorder, gastrointestinal (GI) symptoms, and erectile dysfunction (ED) in the 0-2, 2-5, 5-10 years prediagnosis/match date. Poisson regression adjusting for age, sex, and SES estimated the inflection points in the case group at which the rate of prescriptions changed from baseline, identifying the start of diagnostic windows. In total, there were 9662 patients in the case group and 56 455 in the control group. Positive associations were found between seven prescriptions and MS diagnosis, with highest odds ratios (3-7 times) in the 2 years prediagnosis. In the all-prescription analysis, inflection points were identified for: GI (69-72 months, 95% confidence interval [CI] = 51 to 90), LUTS (69-72 months, 95% CI = 30 to 111), UTI (66-69 months, 95% CI = 45 to 90), migraine (63-66 months, 95% CI = 27 to 102), ED (60-63 months, 95% CI = 30 to 93), and anxiety/depression (9-12 months, 95% CI = 3 to 18). Prescriptions for symptoms of possible MS were more common in the case group than the control group up to 10 years prediagnosis. Prescription rates changed years prediagnosis, indicating potential opportunities for earlier detection, but broad CIs demonstrated uncertainty regarding diagnostic window duration.
Medical subject headings
- Multiple Sclerosis
- Practice Patterns, Physicians'
- Drug Prescriptions